Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs

Brewer, 1998, Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?, J Fam Pract, 47, 185 Dolovich, 2000, A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism, Arch Intern Med, 160, 181, 10.1001/archinte.160.2.181 Gould, 1999, Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis, Ann Intern Med, 130, 789, 10.7326/0003-4819-130-10-199905180-00002 Green, 1994, Low molecular weight heparin, Pharmacol Rev, 46, 89 Hettiarachchi, 1998, Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism, Curr Opin Pulm Med, 4, 220, 10.1097/00063198-199807000-00007 Howard, 1997, Dalteparin, Ann Pharmacother, 31, 192, 10.1177/106002809703100212 Hunt, 1998, Low-molecular-weight heparins in clinical practice, South Med J, 91, 2, 10.1097/00007611-199801000-00001 Leizorovicz, 1996, Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An updated meta-analysis, Drugs, 52, 30, 10.2165/00003495-199600527-00006 Lensing, 1995, Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis, Arch Intern Med, 155, 601, 10.1001/archinte.1995.00430060059007 Martineau, 1998, Low-molecular-weight heparins in the treatment of deep-vein thrombosis, Ann Pharmacother, 32, 588, 10.1345/aph.16450 Rocha, 2000, Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis, Haematologica, 85, 935 Siragusa, 1996, Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism, Am J Med, 100, 269, 10.1016/S0002-9343(97)89484-3 van den Belt, 1998, Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis—an economic evaluation. TASMAN Study Group, Thromb Haemost, 79, 259, 10.1055/s-0037-1614975 van der Heijden, 2000, For the initial treatment of venous thromboembolism, Thromb Res, 100, V121, 10.1016/S0049-3848(00)00272-3 Segal, 2003 Gebo, 2002 Schein, 2001 Richardson, 1995, Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group, JAMA, 273, 1610, 10.1001/jama.1995.03520440064038 Richardson, 1995, Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-Based Medicine Working Group, JAMA, 273, 1292, 10.1001/jama.1995.03520400062046 Berlin, 1997, Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group, Lancet, 350, 185, 10.1016/S0140-6736(05)62352-5 Garbutt, 1999, Pharmacological treatment of alcohol dependence, JAMA, 281, 1318, 10.1001/jama.281.14.1318 Belcaro, 1999, Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis, Angiology, 50, 781, 10.1177/000331979905001001 Grau, 2001, Home treatment of deep venous thrombosis with low molecular weight heparin, Am J Hematol, 67, 10, 10.1002/ajh.1069 Huse, 2002, Outpatient treatment of venous thromboembolism with low-molecular-weight heparin, Am J Manag Care, 8, S10 Koopman, 1996, Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The TASMAN Study Group, N Engl J Med, 334, 682, 10.1056/NEJM199603143341102 Levine, 1996, A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis, N Engl J Med, 334, 677, 10.1056/NEJM199603143341101 Pearson, 1999, An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin, Eff Clin Pract, 2, 210 Smith, 2002, Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin, Intern Med J, 32, 29, 10.1046/j.1445-5994.2002.00146.x Vinson, 2001, Outpatient treatment of deep venous thrombosis, Ann Emerg Med, 37, 251, 10.1067/mem.2001.113703 Boccalon, 2000, Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin, Arch Intern Med, 160, 1769, 10.1001/archinte.160.12.1769 Kovacs, 2000, Outpatient treatment of pulmonary embolism with dalteparin, Thromb Haemost, 83, 209, 10.1055/s-0037-1613787 de Lissovoy, 2000, Cost for inpatient care of venous thrombosis, Arch Intern Med, 160, 3160, 10.1001/archinte.160.20.3160 Estrada, 2000, Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis, J Gen Intern Med, 15, 108, 10.1046/j.1525-1497.2000.03349.x Hull, 1997, Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective, Arch Intern Med, 157, 289, 10.1001/archinte.1997.00440240051008 Lloyd, 1997, Economic evaluation of the use of nadroparin in the treatment of deep-vein thrombosis in Switzerland, Ann Pharmacother, 31, 842, 10.1177/106002809703100705 O'Brien, 1999, Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis, Arch Intern Med, 159, 2298, 10.1001/archinte.159.19.2298 Rodger, 1998, Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis, CMAJ, 159, 931 Tillman, 2000, Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization, Arch Intern Med, 160, 2926, 10.1001/archinte.160.19.2926 Spyropoulos, 2002, Management of acute proximal deep vein thrombosis, Chest, 122, 108, 10.1378/chest.122.1.108